Based on advanced genetic guidance, the Amplis Report provides you with a new powerful tool to guide your prescribing decisions. Manage issues of trial-and-error prescribing, medication side effects and adverse medication reactions with one simple cheek swab.
CNSDose was founded by Associate Professor Singh and Dr Harris Eyre after meeting in 2015 at the Pivot Summit—a digital strategy conference in Victoria. A year earlier, Eyre describes having an epiphany while on a Fulbright scholarship in the United States. He was aware that mental illness is hugely burdensome to individuals and societies, and realised that a number of technologies exist—such as genomics, virtual reality, microsensors and big data analytics—which could be employed to address the inadequacies in its diagnosis, treatment and prevention.
“There is a disconnect between ‘day to day’ clinical medicine, ‘day to day’ academic research, ‘day to day’ health system management and the need to develop new technologies,” says Eyre.
A new powerful tool to guide your prescribing decisions